IRTC

iRhythm Holdings, Inc.
CAPPED RATING

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

iRhythm Holdings, Inc. (IRTC) is rated C- (1.9/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B-); its weakest is Revisions (F).

Quantitative Factor Evaluation • Updated

Overall Rating
1.9 / 5.0
C-
Value
D+
Factor Score 1.7 / 5.0
Growth
C+
Factor Score 2.5 / 5.0
Profitability
B-
Factor Score 3.1 / 5.0
Momentum
C
Factor Score 2.2 / 5.0
Revisions
F
Factor Score 0.0 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 56.7
EV / EBITDA 68.9
Rev Growth YoY 14.9%
Gross Margin 71.9%
Price Return 3M -28.0%
Price Return 12M -49.7%
Catalyst Signal 0.00
Market Cap $2.9B
TTM Revenue $854.0M
Price / Sales 3.4
ROE -25.8%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-12 D+ (1.7) C+ (2.5) B- (3.1) C (2.2) F (0.0) C- (1.9)
2026-11-05 D (1.2) B (3.4) B- (3.1) C+ (2.7) C+ (2.7) C+ (2.6)
2026-10-29 D (1.2) B (3.3) B- (3.1) C+ (2.6) C+ (2.7) C+ (2.6)
2026-10-22 D (1.3) B (3.3) B- (3.1) C+ (2.5) C+ (2.6) C+ (2.6)
2026-10-15 D (1.4) B (3.3) B- (3.1) C (2.3) C+ (2.6) C+ (2.6)
Page 1 of 3